Mito Biopharma currently has not partnered its programs with other companies. However, the company has established various collaborative and development relationships with outside parties such as CROs, Rutgers University, and certain government departments to allow more efficient advancement of its technology and lead compounds. Structurally, Mito Biopharma deploys a virtual corporate model at this time which enhances efficiency while allowing access and leveraging of outside expertise effectively.  Going forward, Mito Biopharma will seek appropriate strategic relationships to further advance its development compounds into broader therapeutic areas.